Sep 9, 2026 10:22PM
Sep 9, 2026 10:21PM
Aug 30, 2026 07:45AM
Aug 20, 2026 08:00AM
Jul 28, 2026 08:00AM
Jul 2, 2026 08:00AM
Jun 15, 2026 02:30AM Bayer receives FDA approval for lowest-dose MRI contrast agent
Jun 15, 2026 02:30AM
Jun 5, 2026 06:40AM
Jun 2, 2026 08:00AM
May 21, 2026 08:00AM
May 21, 2026 08:00AM
May 21, 2026 02:30AM
May 21, 2026 02:30AM Bayer’s KERENDIA® (finerenone) Granted Priority Review of Supplemental New Drug Application by U.S. FDA for Treatment of Adults with Type 1 Diabetes and Chronic Kidney Disease
May 19, 2026 02:30AM
May 19, 2026 02:30AM
May 18, 2026 08:41AM
May 18, 2026 08:41AM
May 7, 2026 02:30AM
Mar 26, 2026 09:55AM
Mar 16, 2026 03:30AM KERENDIA® (finerenone) Meets Primary Endpoint in Investigational Phase III FIND-CKD Study in Patients with Non-Diabetic Chronic Kidney Disease
Mar 4, 2026 08:00AM
Mar 4, 2026 08:00AM
Feb 23, 2026 10:28AM
Feb 5, 2026 12:15PM
Feb 5, 2026 12:15PM
Jan 29, 2026 08:30AM
Jan 13, 2026 02:15PM Bayer Accelerates Pharma Growth on High-Value Portfolio
Jan 13, 2026 09:00AM
Jan 12, 2026 08:00AM
Dec 4, 2025 02:30AM
Dec 2, 2025 08:05AM
Dec 1, 2025 11:30AM
Nov 23, 2025 11:28AM
Nov 20, 2025 08:00AM FDA approves Bayer's HYRNUO for HER2-mutated lung cancer treatment
Nov 20, 2025 08:00AM
Nov 6, 2025 09:00AM
Oct 24, 2025 01:25PM
Oct 24, 2025 01:25PM
Oct 7, 2025 08:21AM
Oct 7, 2025 02:00AM
Sep 25, 2025 08:00AM Bayer to Highlight New Data for KERENDIA® (finerenone) at Heart Failure Society of America (HFSA) Annual Scientific Meeting 2025
Sep 22, 2025 06:00AM
Aug 27, 2025 07:50AM

330,738 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All